PURPOSE: To determine predictive factors of late radiation fibrosis (RF) after conformal radiotherapy (3D-RT) in non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: Ninety-six patients with Stage IA-IIIB NSCLC were included in a prospective trial. Clinical evaluation, chest X-ray, and pulmonary functional tests including diffusion parameters were performed before and 6 months after radiotherapy. An independent panel of experts prospectively analyzed RF, using Late Effects in Normal Tissues-Subjective, Objective, Management and Analytic scales classification. Logistic regression analysis was performed to identify relationships between clinical, functional, or treatment parameters and incidence of RF. Variations of circulating serum levels of pro-inflammatory (interleukin-6, tumor necrosis factor alpha, tumor growth factor beta1) and anti-inflammatory (interleukin-10) cytokines during 3D-RT were examined to identify correlations with RF. RESULTS: Of the 96 patients included, 72 were evaluable for RF at 6 months. Thirty-seven (51.4%) developed RF (Grade >or=1), including six severe RF (Grades 2-3; 8.3%). In univariate analysis, only poor Karnofsky Performance Status and previous acute radiation pneumonitis were associated with RF (p < 0.05). Dosimetric factors (mean lung dose, percentage of lung volume receiving more than 10, 20, 30, 40, and 50 Gy) were highly correlated with RF (p < 0.001). In multivariate analysis, previous acute radiation pneumonitis and dosimetric parameters were significantly correlated with RF occurrence. It was not significantly correlated either with cytokines at baseline or with their variation during 3D-RT. CONCLUSIONS: This study confirms the importance of dosimetric parameters to limit the risk of RF. Contrary to acute radiation pneumonitis, RF was not correlated to cytokine variations during 3D-RT.
PURPOSE: To determine predictive factors of late radiation fibrosis (RF) after conformal radiotherapy (3D-RT) in non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: Ninety-six patients with Stage IA-IIIB NSCLC were included in a prospective trial. Clinical evaluation, chest X-ray, and pulmonary functional tests including diffusion parameters were performed before and 6 months after radiotherapy. An independent panel of experts prospectively analyzed RF, using Late Effects in Normal Tissues-Subjective, Objective, Management and Analytic scales classification. Logistic regression analysis was performed to identify relationships between clinical, functional, or treatment parameters and incidence of RF. Variations of circulating serum levels of pro-inflammatory (interleukin-6, tumor necrosis factor alpha, tumor growth factor beta1) and anti-inflammatory (interleukin-10) cytokines during 3D-RT were examined to identify correlations with RF. RESULTS: Of the 96 patients included, 72 were evaluable for RF at 6 months. Thirty-seven (51.4%) developed RF (Grade >or=1), including six severe RF (Grades 2-3; 8.3%). In univariate analysis, only poor Karnofsky Performance Status and previous acute radiation pneumonitis were associated with RF (p < 0.05). Dosimetric factors (mean lung dose, percentage of lung volume receiving more than 10, 20, 30, 40, and 50 Gy) were highly correlated with RF (p < 0.001). In multivariate analysis, previous acute radiation pneumonitis and dosimetric parameters were significantly correlated with RF occurrence. It was not significantly correlated either with cytokines at baseline or with their variation during 3D-RT. CONCLUSIONS: This study confirms the importance of dosimetric parameters to limit the risk of RF. Contrary to acute radiation pneumonitis, RF was not correlated to cytokine variations during 3D-RT.
Authors: Ronny Kalash; Michael W Epperly; Julie Goff; Tracy Dixon; Melissa M Sprachman; Xichen Zhang; Donna Shields; Shaonan Cao; Darcy Franicola; Peter Wipf; Hebist Berhane; Hong Wang; Jeremiah Au; Joel S Greenberger Journal: Radiat Res Date: 2013-10-14 Impact factor: 2.841
Authors: Elizabeth L Travis; Girish Rachakonda; Xinhui Zhou; Katrina Korhonen; Konjeti R Sekhar; Swati Biswas; Michael L Freeman Journal: Free Radic Biol Med Date: 2011-06-12 Impact factor: 7.376
Authors: Ronny Kalash; Hebist Berhane; Jeremiah Au; Byung Han Rhieu; Michael W Epperly; Julie Goff; Tracy Dixon; Hong Wang; Xichen Zhang; Darcy Franicola; Ashwin Shinde; Joel S Greenberger Journal: In Vivo Date: 2014 Mar-Apr Impact factor: 2.155
Authors: Robert M Tighe; Karissa Heck; Erik Soderblom; Shutang Zhou; Anastasiya Birukova; Kenneth Young; Douglas Rouse; Jessica Vidas; Miglena K Komforti; Christopher B Toomey; Frank Cuttitta; Mary E Sunday Journal: Am J Pathol Date: 2019-03-18 Impact factor: 4.307
Authors: Ronny Kalash; Hebist Berhane; Julie Goff; Frank Houghton; Michael W Epperly; Tracy Dixon; Xichen Zhang; Melissa M Sprachman; Peter Wipf; Darcy Franicola; Hong Wang; Joel S Greenberger Journal: In Vivo Date: 2013 May-Jun Impact factor: 2.155
Authors: Tokihiro Yamamoto; Sven Kabus; Matthieu Bal; Karl Bzdusek; Paul J Keall; Cari Wright; Stanley H Benedict; Megan E Daly Journal: Int J Radiat Oncol Biol Phys Date: 2018-05-04 Impact factor: 7.038
Authors: Pegah Jahangiri; Kamyar Pournazari; Drew A Torigian; Thomas J Werner; Samuel Swisher-McClure; Charles B Simone; Abass Alavi Journal: Eur J Nucl Med Mol Imaging Date: 2018-09-18 Impact factor: 9.236